Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC in Posterior Cervical Fusion
NCT02068547Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2014
- Primary completion
- Apr 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, single-blind trial of autologous bone marrow cell concentrate in cervical myelopathy and cervical radiculopathy (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Rate of Fusion at 24 months. Started Feb 2014; status: terminated.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
cervical myelopathycervical radiculopathy
Beyond the preview
Go deeper on NCT02068547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068547.